1329651-11-7
Chemical Structure
Mirodenafil-d7
Synonym(s): SK3530-d7
- CAS No.: 1329651-11-7
- Formula:C26H30D7N5O5S
- Molecular Weight:538.71
IUPAC Name: N'-(2-fluoro-3-methyl-5-(pyridazin-4-yl)benzoyl)benzenesulfonohydrazide
InChIKey: MIJFNYMSCFYZNY-XSIGYUCQSA-N
SMILES: O=C1C2=C(N=C(N1)C3=CC(S(=O)(N4CCN(CC4)CCO)=O)=CC=C3OC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])C(CCC)=CN2CC
Biological Activity: Mirodenafil-d7 (SK3530-d7) is the deuterium labeled Mirodenafil (HY-14930). Mirodenafil (SK3530) is an orally active, potent, reversible, and selective?phosphodiesterase?5 (PDE5)?inhibitor. Mirodenafil is a?glucocorticoid receptor?(GR)?modulator Mirodenafil activates the?Wnt/β-catenin?signaling pathway by downregulating Dkk1 expression. Mirodenafil can be used for the research of erectile dysfunction (ED), Alzheimer’s disease (AD) and systemic sclerosis (SSc).
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Mirodenafil-d7 | Mirodenafil-d7 (SK3530-d7) is the deuterium labeled Mirodenafil (HY-14930). Mirodenafil (SK3530) is an orally active, potent, reversible, and selective?phosphodiesterase?5 (PDE5)?inhibitor. Mirodenafil is a?glucocorticoid receptor?(GR)?modulator Mirodenafil activates the?Wnt/β-catenin?signaling pathway by downregulating Dkk1 expression. Mirodenafil can be used for the research of erectile dysfunction (ED), Alzheimer’s disease (AD) and systemic sclerosis (SSc). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mirodenafil (Standard) | ≥98% | Mirodenafil (Standard) is the analytical standard of Mirodenafil. This product is intended for research and analytical applications. Mirodenafil (SK3530) is an orally active, potent, reversible, and selective phosphodiesterase 5 (PDE5) inhibitor. Mirodenafil is a glucocorticoid receptor (GR) modulator Mirodenafil activates the Wnt/β-catenin signaling pathway by downregulating Dkk1 expression. Mirodenafil can be used for the research of erectile dysfunction (ED), Alzheimer’s disease (AD) and systemic sclerosis (SSc). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mirodenafil | 99.88% | Mirodenafil (SK3530) is an orally active, potent, reversible, and selective phosphodiesterase 5 (PDE5) inhibitor. Mirodenafil is a glucocorticoid receptor (GR) modulator Mirodenafil activates the Wnt/β-catenin signaling pathway by downregulating Dkk1 expression. Mirodenafil can be used for the research of erectile dysfunction (ED), Alzheimer’s disease (AD) and systemic sclerosis (SSc). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
